SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Tremfya Shows Significant BASDAI Improvement Versus Placebo in Phase 4 Study

Johnson & Johnson said Tremfya showed statistically significant improvement in BASDAI score versus placebo in a Phase 4 study.

JNJ

Related stories